114 related articles for article (PubMed ID: 25356488)
1. 15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003).
Feng SS
J Control Release; 2014 Sep; 190():58-60. PubMed ID: 25356488
[No Abstract] [Full Text] [Related]
2. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Mu L; Feng SS
J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
[TBL] [Abstract][Full Text] [Related]
3. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy.
Zhang Z; Lee SH; Gan CW; Feng SS
Pharm Res; 2008 Aug; 25(8):1925-35. PubMed ID: 18509603
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
Zhao L; Feng SS
J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
Win KY; Feng SS
Biomaterials; 2006 Apr; 27(10):2285-91. PubMed ID: 16313953
[TBL] [Abstract][Full Text] [Related]
8. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
9. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.
Mu L; Feng SS
Pharm Res; 2003 Nov; 20(11):1864-72. PubMed ID: 14661934
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
11. 23. From stealthy, controlled release polymersomes to cylinder-shaped 'filomicelles' for imaging and delivery: Original research article: Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles, 2004.
Nair PR; Discher DE
J Control Release; 2014 Sep; 190():72-4. PubMed ID: 25356496
[No Abstract] [Full Text] [Related]
12. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
Xie J; Wang CH
Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
Mu L; Feng SS
J Control Release; 2002 Apr; 80(1-3):129-44. PubMed ID: 11943393
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.
Zhang Z; Feng SS
Int J Pharm; 2006 Nov; 324(2):191-8. PubMed ID: 16842944
[TBL] [Abstract][Full Text] [Related]
15. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
16. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and drug release property of paclitaxel nanoparticles].
Wang TW; Wu Y; Li MJ; Gao HX
Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
[TBL] [Abstract][Full Text] [Related]
18. [Studies on paclitaxel-loaded methoxy poly (ethylene glycol)/poly (L-lactic acid) diblock copolymer nanoparticles].
Deng L; Sun D; Zhang Y; Huo J; Yuan Y; Dong A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):715-8. PubMed ID: 16156257
[TBL] [Abstract][Full Text] [Related]
19. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
20. Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation.
Wang J; Ng CW; Win KY; Shoemakers P; Lee TK; Feng SS; Wang CH
J Microencapsul; 2003; 20(3):317-27. PubMed ID: 12881113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]